Persistent Growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health related quality of life

Publication of impact on health-related quality of life from 3 year data with vosoritide. These data suggest that after 3 years of treatment, vosoritide demonstrates a…

Read More

What is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?

Despite the recognized expertise of pediatric endocrinologists, children with skeletal dysplasias have not been consistently managed by these physicians. Growth-altering treatments have broadened the role of…

Read More

Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study- a multicenter retrospective cohort study of achondroplasia in the US

Achondroplasia growth charts included in this article. Achondroplasia is the most common genetic skeletal disorder causing disproportionate short stature/dwarfism. Common additionalfeatures include spinal stenosis, midface retrusion,…

Read More

PES 2019 Transgender Statement

Read More

Improving Long-Term Outcomes of Youth with Lipid Abnormalities – Expanding the Role of Pediatric Endocrinologists

Read More

Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity

Read More

Statement on Gender-Affirmative Approach to Care from the Pediatric Endocrine Society Special Interest Group on Transgender Health (Curr Opin, Peds 2017)

Read More

PES Statement Promoting Safety of Transgender Youth (PES Statement 2017)

Read More

UCSF Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People

Read More

Hypophosphatasia and Asfotase Alfa – ALEXION Website

Read More